Pseudomonas aeruginosa biofilms are more susceptible to ciprofloxacin than to tobramycin

International Journal of Antimicrobial Agents

Volumn 7, Issue 4, 1996, Pages 251-256

  Preston, Carol A K ^a   Khoury, Antoine E ^b   Reid, Gregor ^c,d   Bruce, Andrew W ^a   Costerton, J William ^e  

^a Toronto General Division   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^e MONTANA STATE UNIVERSITY   (United States)

Author keywords

biofilms; ciprofloxacin; Pseudomonas; tobramycin

Indexed keywords

CIPROFLOXACIN; TOBRAMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM ADHERENCE; BACTERIUM ISOLATION; BIOFILM; CONTROLLED STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SCANNING ELECTRON MICROSCOPY;

EID: 0030267771     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(96)00330-5     Document Type: Article

References (15)

1. [1] Costerton JW, Irvin RT, Cheng KJ. The bacterial glycocalyx in nature and disease. Annu. Rev. Microbiol. 1981;35:299-324.
2. [2] Nickel JC, Ruseska I, Wright JB, Costerton JW. Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material. Antimicrob. Agents Chemother. 1985;27:619-624.
3. [3] Costerton JW, Cheng KJ, Geesey GG, Ladd TI, Nickel JC, Dasgupta M, Marrie TJ. Bacterial biofilms in nature and disease. Annu. Rev. Microbiol. 1987;41:435-464.
4. [4] Hustinx WNM, Verbrugh HA. Catheter-associated urinary tract infections: epidemiological, preventive and therapeutic considerations. Int. J. Antimicrob. Agents 1994;4:117-123.
5. [5] Warren JW, Muncie HL, Berquist, EJ, Hoopes JM. Sequelae and management of urinary infections in the patient requiring chronic catheterization. J. Urol. 1981;125:1-8.
6. [6] Furusawa T, Uete T, Kawada T, Okuma A. Resistance to cefsulodin and gentamycin in five areas of Japan between 1980 and 1983. J. Antimicrob. Chemother. 1986;17:755-762.
7. [7] Murray BE. Problems and mechanisms of antimicrobial resistance. Infect. Dis. Clin North Am. 1989;3:423-439.
8. [8] McCoy WF, Costerton JW. Fouling biofilm development in tubular flow systems. Dev. Ind. Microbiol. 1982;23:551-558.
9. [9] Zufferey J, Rime B, Francioli P, Bille J. Simple method for rapid diagnosis of catheter-associated infection by direct acridine orange staining of catheter tips. J. Clin. Microbiol. 1988;26:175-177.
10. [10] Anwar H, van Biesen T, Dasgupta M, Lam K, Costerton JW. Interaction of biofilm bacteria with antibiotics in a novel in vitro chemostat system. Antimicrob. Agents Chemother. 1989;33:1824-1826.
11. [11] Gilbert P, Collier PJ, Brown MRW. Influence of growth rate on susceptibility to antimicrobial agents: biofilms, cell cycle, dormancy and stringent response. Antimicrob. Agents Chemother. 1990;34:1865-1868.
12. [12] Evans DJ, Allison DG, Brown MRW, Gilbert P. Susceptibility of Pseudomonas aeruginosa and Escherichia coli biofilms towards ciprofloxacin: effect of specific growth rate. J. Antimicrob. Chemother. 1991;27:177-184.
13. [13] Reid G, Dafoe L, Delaney G, Lacerte M, Valvano M, Hayes KC. Use of adhesion counts to help predict symptomatic infection and the ability of fluoroquinolones to penetrate bacterial biofilms on the bladder cells of spinal cord injured patients. Paraplegia 1994;32:468-472.
14. [14] Pearson RD, Steigbigel RT, Davis HT, Chapman SW. Method for reliable determination of minimal lethal antibiotic concentration. Antimicrob. Agents Chemother. 1980;18:699-708.
15. [15] Andriole VT. Quinolones. In G.L. Mandell, R.G. Douglas, Jr., and J.E. Bennet (ed.), Principles and practices of infectious disease. Churchill Livingstone, New York, pp. 334-345, 1990.